previous compound ID: 1137 next compound
InChIKey: JZQKKSLKJUAGIC-UHFFFAOYSA-N
SMILES: CC(C)NCC(COC1=CC=CC2=C1C=CN2)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "R Robert" "DY Thomas" "GW Carlile" "J Goepp" "JW Hanrahan" "B Kus" "J Liao" "D Rotin" "E Matthes"

chemical graph of compound 1137





CID is 4828
synonyms found at PubChem are:
pindolol, Prinodolol, Visken, Betapindol, 13523-86-9, Carvisken, Durapindol, Pinbetol, Calvisken, Decreten, Pectobloc, Pynastin, Blocklin L, Pindololum, LB-46, Glauco-visken, Glauco-Viskin, Blockin L, LB 46, Prindolol, (+-)-Pindolol, Blocklin-L, DL-Pindolol, Pindololum [INN-Latin], 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole, Blocklin, 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol, 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol, 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol, Carvisken (TN), 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole, Blocklin-L (TN), Visken (TN), CCRIS 9215, HSDB 6539, Pindolol [USAN:INN:BAN:JAN], 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol, EINECS 236-867-9, EINECS 244-623-8, 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol, 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-, 2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-, BRN 1536506, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol, CHEBI:8214, DL-LB 46, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol, 2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-, JZQKKSLKJUAGIC-UHFFFAOYSA-N, P-6820, 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol, NCGC00015786-11, (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol, DSSTox_CID_3476, P 0778, DSSTox_RID_77043, DSSTox_GSID_23476, DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole, 1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol, 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol, 1-[1H-INDOL-4-YLOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL, 2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-, 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-, SMR000059120, SR-01000000027, LB46, (rs)-pindolol, Betapindol (TN), Durapindol (TN), Calvisken (TN), Pectobloc (TN), Prindolol (TN), Decreten (TN), Pinbetol (TN), Pynastin (TN), Prestwick_397, Blocklin L (TN), CAS-13523-86-9, Blockin L (TN), Pindolol [USAN:USP:INN:BAN:JAN], Glauco-Visken (TN), Spectrum_001109, (.+/-.)-Pindolol, Prestwick0_000090, Prestwick1_000090, Prestwick2_000090, Prestwick3_000090, Spectrum2_001285, Spectrum3_000547, Spectrum4_000479, Spectrum5_001266, (R,S)-PINDOLOL, CHEMBL500, D0F2PO, GTPL91, PINDOLOL,(-), AC1L1J1N, AC1Q1QC1, SCHEMBL5219, Lopac0_000955, Oprea1_770884, BSPBio_000020, BSPBio_002193, KBioGR_000958, KBioSS_001589, 5-21-03-00017 (Beilstein Handbook Reference), MLS000069496, MLS002548891, DivK1c_000837, SPECTRUM1500488, Pindolol (JP15/USP/INN), Pindolol (JP17/USP/INN), SPBio_001289, SPBio_001959, BPBio1_000022, DTXSID8023476, CTK8G2432, HMS502J19, KBio1_000837, KBio2_001589, KBio2_004157, KBio2_006725, KBio3_001693, MolPort-001-792-503, NINDS_000837, HMS1568A22, HMS1920H16, HMS2089I21, HMS2091P20, HMS2095A22, HMS3259I07, HMS3262P12, HMS3267K17, HMS3369E14, HMS3712A22, Pharmakon1600-01500488, (+-)-lb46, HY-B0982, Pindolol, >=98% (TLC), powder, Tox21_110221, Tox21_500955, BDBM50019443, BG0392, CCG-39223, MFCD00010530, NSC757276, PDSP1_000771, PDSP1_000772, PDSP2_000759, PDSP2_000760, (+/-)-Pindolol-d7(iso-propyl-d7), AKOS015969756, Tox21_110221_1, API0000920, CS-4473, DB00960, LP00955, MCULE-7764948919, NC00467, NSC-757276, IDI1_000837, NCGC00015786-06, NCGC00015786-07, NCGC00015786-08, NCGC00015786-09, NCGC00015786-10, NCGC00015786-13, NCGC00015786-14, NCGC00015786-16, NCGC00015786-20, NCGC00024925-03, NCGC00024925-04, NCGC00024925-05, NCGC00024925-06, NCGC00024925-07, NCGC00261640-01, AN-18448, CC-33796, CPD000059120, SAM002264631, SC-25688, SBI-0050929.P004, LS-122385, AB00052072, EU-0100955, FT-0630406, ST50319990, Z3376, C07445, D00513, AB00052072-11, AB00052072_12, AB00052072_13, 1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol, 523P869, C-15218, L000006, 3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol, SR-01000000027-2, SR-01000000027-4, SR-01000000027-5, SR-01000000027-7, (+-)-4-(2-hydroxy-3-(isopropylamino)propoxy)indole, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol, BRD-A97701745-001-05-3, BRD-A97701745-001-09-5, 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #, Pindolol, European Pharmacopoeia (EP) Reference Standard, [2-hydroxy-3-(1H-indol-4-yloxy)propyl](propan-2-yl)amine, 1-(1h-indol-4-yloxy)-3-((1-methylethyl)amino)-2-propano, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol), Pindolol, United States Pharmacopeia (USP) Reference Standard, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol), 21870-06-4